Cambridge Investment Research Advisors’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-4,420
| Closed | -$232K | – | 2579 |
|
|
2020
Q2 | $232K | Sell |
4,420
-3,608
| -45% | -$189K | ﹤0.01% | 2075 |
|
|
2020
Q1 | $269K | Buy |
8,028
+2,450
| +44% | +$82.1K | ﹤0.01% | 1737 |
|
|
2019
Q4 | $253K | Sell |
5,578
-1,026
| -16% | -$46.5K | ﹤0.01% | 2024 |
|
|
2019
Q3 | $251K | Buy |
6,604
+185
| +3% | +$7.03K | ﹤0.01% | 1953 |
|
|
2019
Q2 | $279K | Hold |
6,419
| – | – | ﹤0.01% | 1781 |
|
|
2019
Q1 | $244K | Buy |
6,419
+447
| +7% | +$17K | ﹤0.01% | 1941 |
|
|
2018
Q4 | $257K | Sell |
5,972
-651
| -10% | -$28K | ﹤0.01% | 1760 |
|
|
2018
Q3 | $326K | Buy |
+6,623
| New | +$326K | ﹤0.01% | 1742 |
|